Bevaro (bevacizumab biosimilar)
/ Cadila
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 25, 2020
Cadila Pharmaceuticals Launches Avastin Biosimilar in India
(Center for Biosimilars)
- "Ahmedabad-based Cadila Pharmaceuticals said it has launched a bevacizumab biosimilar (Bevaro) on the Indian market for the treatment of multiple cancers....Bevaro will be made available in a single-dose vials of 100 mg and 400 mg."
Biosimilar launch • Colorectal Cancer • Glioblastoma • Oncology
1 to 1
Of
1
Go to page
1